secwatch.observer — SEC 8-K summary
======================================

Issuer:     Caribou Biosciences, Inc. (CRBU)
CIK:        0001619856
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001619856-23-000076
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Caribou stockholders elect Guggenhime, Johnson, Whiting as Class II directors and ratify Deloitte as auditor
--------------------------------------------------------------------------------

- Andrew Guggenhime: 31.0M votes for, 5.3M withheld, 9.4M broker non-votes.
- David L. Johnson: 31.8M for, 4.5M withheld, 9.4M broker non-votes.
- Nancy Whiting: 31.9M for, 4.5M withheld, 9.4M broker non-votes.
- Ratification of Deloitte & Touche as independent auditor: 45.7M for, 51.8K against, 82.4K abstain.
- Annual meeting held June 15, 2023; all proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1619856/000161985623000076/0001619856-23-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1619856/000161985623000076/crbu-20230615.htm
  HTML page:      https://secwatch.observer/filing/0001619856-23-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer